delivery type mark
সারা বাংলাদেশ থেকে অর্ডার করা যাবে।


rx_reqRequire Prescription
Generic: Crystalline Mitomycin-C
recently bought407 people recently viewed this.
Best Price
10% OFF
Out of Stock

Additional Offers

Show all
Cashback ৳100 : For purchasing above ৳5000+
Cashback ৳80 : For purchasing above ৳4000+
Cashback ৳60 : For purchasing above ৳3000+
Select Language
descriptionMedical Overview


Diabetic foot infections, Chronic lymphatic leukaemia, Chronic myelogenous leukaemia, Gastric carcinoma, Colorectal carcinoma, Lung carcinoma, Pancreati... View More


IV Preparation Reconstitute with SWI to a concentration of 0.5 mg/mL IV Administration Administer slow IV push by central line only Flush with 5-1... View More

Adult Dose

Adult: IV Solid tumours Suggested regimen: Initial: 10-20 mg/m2; may repeat 6-8 wkly depending on blood count. Do not repeat if leucocyte and platelet c... View More

Child Dose

Safety and efficacy not established

Renal Dose

Renal Impairment Serum creatinine >1.7 mg/dL: Avoid use CrCl <10 mL/min: Decrease dose by 25% CAPD: Decrease dose by 25%


Thrombocytopenia, coagulation disorders, increase in bleeding tendency due to other causes. Renal impairment, potentially severe infections. Pregnancy a... View More

Mode of Action

Mitomycin is an antineoplastic antibiotic which is enzymatically reduced to its active metabolite within susceptible cells. The active metabolite appear... View More


Repeated haematologic studies are necessary during treatment and for at least 7 wk after discontinuation of the drug. Discontinue use when the leucocyte... View More

Side Effect

>10% Hemolytic uremic syndrome (<15%),Myelosuppression (64%),Nausea/vomiting (14%),Fever (14%) 1-10% Stomatitis (4%),Increased serum creatinine (2%... View More

Pregnancy Category Note

Pregnancy Category: D Lactation: Not known if excreted in breast milk, do not nurse


Increased incidence of cardiotoxicity w/ doxorubicin. Potentially Fatal: Increased risk of intravascular haemolysis and renal failure w/ fluorouracil... View More


The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More

Open in App